Clinical Trial: When Research Goes Wrong

Three patients died in an unapproved medical trial conducted between 2003 and 2004. Now, the executives of Snythes Inc., a medical-device company, are awaiting sentencing this week after pleading guilty to a misdemeanor as “responsible corporate officers,” according to Business Week.

The Synthes officials allegedly bypassed FDA protocol to have surgeons test bone cement in people with spine fractures. The product was not approved for that use, and three people died in the operating room in 2003 and 2004. The patients who died suffered a severe drop in blood pressure following the injections. The surgeons involved could not rule out the bone cement as a factor in the deaths, but it also wasn’t definitively responsible.

Synthes pleaded guilty to corporate health care fraud charges and agreed to pay $23 million in fines.

Prosecutors in the case want one-year prison terms for”human experimentation.” According to prosecutors, the executives not only tested the bone cement on humans, but failed to report the deaths and lied to FDA investigators. Each defendant has lost his job and been fined $100,000.

Although this is an extreme example of a recent case, clinical research fraud allegations are common. Medical and clinical researchers, whether in an academic community or in a practice setting, may be accused of research misconduct, altering data, falsifying results, misrepresenting data, or other forms of research misconduct. It is imperative that the researcher obtain experienced legal counsel to represent him or her in such matters.

An accusation, even if later proven to be unfounded, may unfairly tarnish the personal and professional reputation of the researcher, cause him or her to lose grants, bonuses and promotions and may even lead to termination of employment. There are many additional more serious and far-reaching consequences that may also result.

In addition to possible immediate consequences already mentioned above, the following are other consequences that may result from such complaints being made against a researcher:

  • Suspensions from employment.
  • Termination of employment.
  • Removal from the department or school.
  • Placement into an administrative position or transfer to another campus or another job site.
  • Removal from positions such as Department Chair, Vice Chair, or Lead Investigator positions.
  • The requirement to retract a published article or chapter in a book (or certain potions of it).
    Please note: if this occurs, there are a number of websites and organizations which monitor such matters which will pick up this information and will republish it with the implication that the researcher was required to do this because of falsification of data or lack of integrity. This alone will permanently tarnish the reputation of the researcher.
  • A requirement that the institution refund the grant money for the grant.
  • Loss of tenure of the researcher.
  • Loss of the authority of the researcher to participate in any other government contracting activities (often referred to as “debarment” or exclusion”).
    This will also cause the researcher’s name and identifying information to be placed on websites and list maintained by the General Services Administration (GSA) and other federal agencies. This also prohibits a person who is “debarred” form being an owner, operator, employee or contractor of anyone else (or any other business entity) that is a government contractor. This also causes the researcher to be placed on the List of Excluded Individuals and Entities (LEIE) maintained by the Office of the Inspector General (OIG) of the U.S. Department of Health and Human Services (HHS), which means that the researcher will also be excluded form the Medicare Program and any state Medicaid programs.
  • Reporting to the National Practitioner Data Bank (NPDB) for any individual who is a licensed health professional such as a medical doctor or registered nurse.
  • Loss of any future grants by the individual.
  • Publication on the research fraud website maintained by the National Institutes of Health (NIH) Office of Research Integrity (ORI).
  • Administrative discipline by the institution overseeing the investigation or research.
  • Civil or administrative complaints being bought for the recovery of salaries, bonuses, expenses, fines or costs of investigation.
  • Criminal prosecution for fraud, theft or other applicable crimes.

In many cases, the researcher accused of such misconduct may actually be the victim of one or more unscrupulous individuals who make the complaint for his or her own ulterior motives. These may include disgruntled former employees or researchers who have lost their jobs or who have been denied renewal of contracts. They may include those who have racial, sexual, religious or other prejudices. They may include those who seek monetary rewards under laws and statutes that promote such reporting (including “whistle blower” and qui tam statutes). They may include persons who perceive that they have been wronged or slighted by the researcher involved. They may include those who make such complaints “preemptively” because they fear that their jobs, contracts or tenure will be jeopardized in the future. In many cases such complaints will be based on the honest motives of the person making the complaint who may have just misunderstood or mis-perceived facts and circumstances. Regardless, the best approach will usually be to take the high road, avoid personal attacks (in most cases) against the complainer, and just defend against the allegations being made with accurate facts, documents and information.

Obtaining an experienced attorney at the earliest stages of an investigation can help the researcher to avoid many pitfalls and mistakes that can harm or even give up defense opportunities the researcher may have. At the very least, legal guidance can assist in presenting the researcher’s side of the case in an effective and organized manner that does not compromise a legal defense.

Going out and retaining an aggressive trial attorney who is unfamiliar with such matters can often be counter-productive and actually lessen the chances of a researcher coming out of an investigation unscathed. A “scorched earth” or “bull in a china shop” approach is often employed by some litigation attorneys not experienced in handling such cases. This is often perceived by the academic or physician members of the committee appointed to investigate the matter as being an impediment to reliable communication and academic honesty, as well as an obstructionist attempt to hide the truth. In some rare cases this may be necessary, but in most it will be counter-productive and will hurt the chances of the researcher obtaining a favorable result.

Although federal statutes and regulations provide the authority and general guidance for conducting such proceedings, including a requirement that any such accusations be reported to the NIH, the actual procedures that must be followed will be set forth in state administrative rules or the internal policies and procedures of the academic institution concerned. The state’s Administrative Procedure Act (APA) will also govern such matters. A working knowledge of how such procedures work and of administrative law is crucial. Although criminal charges may come out of such investigations, a knowledgeable, experienced health law attorney may be able to obtain a resolution without anyone even considering such action.

The Health Law Firm and its attorneys have experience in representing researchers, investigators, academicians and clinicians who are the subject of such complaints. The Health Law Firm and its attorneys also have experience in representing students, employees, researchers, investigators and “whistle blowers” who report such matters including those who become the victim or reprisals and retaliation by the person against whom the report is made.

Don’t wait. Obtain the advice and counsel of experienced attorneys who are familiar with such matters and can assist you before it is too late. For more information visit http://www.TheHealthLawFirm.com.

By |2024-03-14T10:00:27-04:00June 1, 2018|Categories: Health Care Industry, Medical Research, The Health Law Firm Blog|Tags: , , , , |Comments Off on Clinical Trial: When Research Goes Wrong

Implications of Clinical Research Misconduct and Fraud Accusations

One of the most notorious recent cases of research misconduct involved a South Korean stem cell researcher who claimed to have cloned human embryonic stem cells. However, the researcher was accused of fabricating crucial data and charged with fraud and embezzlement. The fraud charges were eventually lifted, but not before the researcher’s reputation was destroyed.

Although accusations of research misconduct and fraud have been present for decades, the number of complaints is on the rise, according to the FDA. In many cases, the researcher accused of such misconduct may actually be the victim of one or more unscrupulous individuals who make the complaint for his or her own ulterior motives. Some researchers may be targeted by an academic institution or the government. Other cases may involve a “whistle blower” who may just have misunderstood the situation.

Generally, a researcher who is said to have committed research fraud or misconduct will be accused of one of the following:

  • Manipulating or concocting research data
  • Failing to disclose financial interest or not properly disclosing conflict of interest
  • Plagiarizing or using another’s ideas without obtaining permission or giving due credit
  • Failing to present data that contradict one’s own previous research
  • Overlooking the use of flawed data or questionable interpretation of data
  • Circumventing certain minor aspects of human-subject requirements (e.g. related to informed consent, confidentiality, etc.)
  • Changing the design, methodology or results of a study in response to pressure from a funding source
  • Ignoring details or cutting corners to meet a deadline
  • Fabricating, falsifying, or mishandling of data for gaining some form of reward or benefit

No matter the circumstances surrounding the case, medical research misconduct and fraud accusations are considered very serious and should not be taken lightly. To combat any of the resultant consequences, a working knowledge of how research misconduct and fraud procedures are handled is crucial. Although criminal charges may come out of such investigations, a knowledgeable, experienced attorney may be able to obtain a resolution without anyone even considering such action.

If you are facing research misconduct or research fruad accusations, please visit our website at www.TheHealthLawFirm.com for more information.

By |2024-03-14T10:00:29-04:00June 1, 2018|Categories: Medical Research, The Health Law Firm Blog|Tags: , , , , , |Comments Off on Implications of Clinical Research Misconduct and Fraud Accusations

Consequences of Clinical Research Fraud and Misconduct

By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law and Michael L. Smith, J.D., R.R.T.,  Board Certified by The Florida Bar in Health Law and Medical

Medical and clinical researchers, whether in an academic community or in a practice setting, spend years on clinical trials and investigations in hopes of contributing to their respective fields. Many of these researchers, however, find themselves defending their reputation after being accused of research fraud or research misconduct.


Why Researchers are Accused of Misconduct.

Although accusations of research fraud and misconduct have been present for decades, the number of complaints is on the rise, according to the FDA. In many cases, the researcher accused of such misconduct may actually be the victim of one or more unscrupulous individuals who make the complaint for his or her own ulterior motives. Some researchers may be targeted by an academic institution or the government. Other cases may involve a “whistle blower” who may just have misunderstood the situation.

Researchers Face Many Difference Accusations.

The most common accusations against researchers include: manipulating or concocting research data, failing to disclose financial interest or not properly disclosing conflict of interest, plagiarizing, failing to present data that contradicts one’s own previous research, overlooking the use of flawed data, and circumventing certain minor aspects of human-subject requirements. Researchers also face an enormous amount of pressure from funding sources. That influence on a researcher can lead to these accusations: changing the design, methodology or results of a study to meet a funding source’s expectations, ignoring details or cutting corners to meet a deadline, fabricating, falsifying or mishandling of data to gain some form of reward or benefit.

A Person and Professional Reputation can be Tarnished.

An accusation, even if later proven to be unfounded, may unfairly tarnish the personal and professional reputation of the researcher, cause the researcher to lose grants, bonuses and promotions, his or her employment may be terminated, or may even face criminal prosecution for fraud, theft or other applicable crimes.

To learn more on clinical research fraud and misconduct, click here.

Well-Known Cases of Research Fraud and Misconduct.

One of the most notorious recent cases of research misconduct involved a stem cell researcher in South Korea who claimed to have cloned human embryonic stem cells. However, the researcher was later accused of fabricating crucial data and charged with fraud and embezzlement. The fraud charges were eventually cleared, but not before the researcher’s reputation was destroyed.

From 1992 to 2002 a former research professor in Vermont falsified and fabricated data in numerous federal grant applications and academic articles. He used two million dollars in government grants – taxpayer money – for studies to perpetrate his fraud. He pled guilty to falsifying 17 grant applications to the National Institutes of Health (NIH) and fabricating data in 10 of his papers. He was ordered to serve one year and a day in federal prison, permanently barred from ever receiving more federal research grants, and ordered to write letters of retraction and correction to a number of scientific journals.

A prominent Massachusetts anesthesiologist admitted to fabricating 21 medical studies that claimed to show benefits from painkillers like Vioxx and Celebrex, according to the hospital where he worked. This data used in the studies was published in several anesthesiology journals between 1996 and 2008. This doctor was sentenced to six months in prison, followed by three years of supervised release. He was ordered to pay a $5,000 fine, forfeit $50,000 to the government and make $360,000 in restitution to pharmaceutical companies. The plea deal effectively ended his career as a physician.

Visit the Office of Research Integrity (ORI) website to learn more on research fraud and misconduct.

Contact Health Law Attorneys Experienced in Clinical Research Fraud and Misconduct.

The Health Law Firm and its attorneys have experience in representing researchers, investigators, academicians and clinicians who are the subject of clinical research fraud and misconduct. The Health Law Firm and its attorneys also have experience in representing students, employees, researchers, investigators and “whistle blowers” who report such matters including those who become the victim or reprisals and retaliation by the person against whom the report is made.

Don’t wait. Obtain the advice and counsel of experienced attorneys who are familiar with such matters and can assist you before it is too late.

If you are facing research misconduct or research fraud accusations, please visit our website for more information at www.TheHealthLawFirm.com or call The Health Law Firm at (407) 331-6620 or (850) 439-1001.

Sources:

“Grantee Misconduct: Dr. Eric T. Poehlman.” National Institutes of Health. (March 7, 2012). From: http://www.nih.gov/news/granteemisconduct.htm

Arak, Joel. “Menopause Doc Fudged Data.” CBS Evening News. (February 11, 2009). From: http://www.cbsnews.com/2100-18563_162-703359.html

Interlandi, Jeneen. “An Unwelcome Discovery.” The New York Times. (October 22, 2006). From: http://www.nytimes.com/2006/10/22/magazine/22sciencefraud.html?pagewanted=all

Winstein, Keith and Armstrong, David. “Top Pain Scientist Fabricated Data in Studies, Hospital Says.” The Wall Street Journal. (March 11, 2009). From: http://online.wsj.com/article/SB123672510903888207.html

About the Authors:George F. Indest III, J.D., M.P.A., LL.M., is Board Certified by The Florida Bar in Health Law.  He is the President and Managing Partner of The Health Law Firm, which has a national practice.  Its main office is in the Orlando, Florida, area.  www.TheHealthLawFirm.com  The Health Law Firm, 1101 Douglas Ave., Altamonte Springs, FL 32714, Phone:  (407) 331-6620.

Michael L. Smith, J.D., R.R.T.is Board Certified by The Florida Bar in Health Law. He is an attorney with The Health Law Firm, which has a national practice. Its main office is in the Orlando, Florida, area. www.TheHealthLawFirm.com The Health Law Firm, 1101 Douglas Ave., Altamonte Springs, FL 32714, Phone: (407) 331-6620.

Go to Top